(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 3.27% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.02%.
Icu Medical's revenue in 2026 is $2,231,262,000.On average, 9 Wall Street analysts forecast ICUI's revenue for 2026 to be $54,812,410,500, with the lowest ICUI revenue forecast at $52,170,551,075, and the highest ICUI revenue forecast at $57,157,986,625. On average, 9 Wall Street analysts forecast ICUI's revenue for 2027 to be $57,256,747,725, with the lowest ICUI revenue forecast at $54,219,843,900, and the highest ICUI revenue forecast at $59,824,536,325.
In 2028, ICUI is forecast to generate $61,108,430,625 in revenue, with the lowest revenue forecast at $58,491,261,475 and the highest revenue forecast at $63,157,723,450.